Chromatin Accessibility Dynamic and AP-1' s Role during Cardiac Reprogramming
Description: Myocardial infarction (MI), also known as heart attack, remains one of the leading causes of death worldwide. Due to the negligible regenerative capacity of the myocardium, the loss of cardiomyocytes is irreversible after MI. By inducing the expression of three genes (Mef2c, Gata4, and Tbx5), the cardiac fibroblast could be reprogrammed into cardiomyocyte-like cells (iCM) in the infarcted heart and promote heart function post-MI. By utilizing single-cell RNA-seq and traditional molecular approaches, our lab has identified waves of transcription remodeling events, including the fast acquisition of cardiac program and the gradual loss of fibroblast program, during cardiac reprogramming. However, how this transcription remodeling was driven by the upstream chromatin landscape is still unclear. My preliminary single cell ATAC-seq data suggests a drastic reconfiguration of chromatin accessibility has taken place and a network of transcription factors (TFs) was identified to play a pivotal role in the shift of chromatin accessibility during the early stage of cardiac reprogramming. I have identified Activator Protein-1(AP-1), a heterodimeric transcription factor complex, as a potential barrier to iCM induction. Therefore, in this study I propose to 1) comprehensively profile the chromatin landscape dynamics of cardiac reprogramming at the single-cell level 2) study the molecular mechanism of how AP-1 regulates cardiac reprogramming through the cooperative interaction with other TFs. To achieve the first aim, I will perform single-cell ATAC sequencing at different reprogramming stages and integrate this data with single-cell RNA sequencing to identify active TFs at each point en route to successful cardiac reprogramming. For the second aim, I will use both genetic and biochemical assays to profile AP-1’s role and its binding partners throughout the reprogramming process. Taken together, our proposed study could provide a comprehensive chromatin landscape profile of cardiac reprogramming. We will also identify important TFs, such as AP-1, and study its mechanism, which could lead us to the improvement of the current reprogramming strategy.
Funder: American Heart Association
Amount: $140,800
Funding type: fellowship
Funder scheme: Postdoctoral Fellowship
Start date: 2021-07-01
End date: 2023-06-30
Investigator: Haofei Wang (lead)
Institutions: University of North Carolina at Chapel Hill, The University of North Carolina at Chapel Hill
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 1
Funder award ID: 827906
OpenAlex ID: G442055270
